About
Jonathan Ilicki is part of Industrifonden's life science team, with a background spanning clinical practice, research, entrepreneurship, and management consulting. He previously worked as a physician, co-founded a medtech startup, scaled operations for a digital healthcare provider, and led growth and internationalization for a VC/PE-backed healthtech scale-up. He holds an MD from Karolinska Institutet, an Executive MBA from the Stockholm School of Economics, and a master's degree in Evidence-Based Medicine from the University of Gothenburg.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- IndustrifondenInvestment Managercurrent2025 — present
- IndustrifondenPrincipal2023 — 2024
- German Marshall Fund of the United StatesMarshall Memorial Fellowcurrent2026 — present
- ToxoTech ABBoard Membercurrent2026 — present
- ZymegoBoard Membercurrent2025 — present
- Tribune TherapeuticsBoard Membercurrent2025 — present
- Gesynta Pharma ABBoard Observercurrent2025 — present
- BOOST PharmaBoard Membercurrent2024 — present
- VitalaBoard Membercurrent2024 — present
- ElyptaBoard Observercurrent2024 — present
- Hypocampus ABBoard Membercurrent2022 — present
- ZalVac ABBoard Member2025 — 2026
- Obama FoundationObama Europe Leader2024 — 2025
- Geras SolutionsBoard Member2022 — 2024
- Platform24Head of Growth2021 — 2023
- Platform24Head of Innovation2019 — 2023
- Platform24Head of Medical Content, acting2020 — 2021
- Ortrud Medical ABBoard Member2015 — 2023
- Ortrud Medical ABCEO and Co-founder2015 — 2017Stockholm, Sweden
- Doktor24Head of Medical Operations2018 — 2019
- The Boston Consulting Group (BCG)Associate2017 — 2018
- Karolinska University HospitalMedical Intern (AT) and Emergency Medicine Resident2013 — 2017
- Karolinska University HospitalJunior Doctor2012 — 2013Stockholm, Sweden
- Sveriges yngre läkares förening (SYLF)Board Member and Editor-in-Chief2012 — 2013Greater Stockholm Metropolitan Area
- Medicor; Medicinska Föreningen, Karolinska InstitutetEditor-in-Chief2008 — 2009Stockholm, Sweden
Skills & more
Strategy51Management64Analysis35Strategic Planning22Public Speaking36Team Leadership31Software as a Service (SaaS)3Entrepreneurship56Start-ups36Clinical Research40Public Health40Healthcare40
+12 more
Project ManagementHospitalsBusiness StrategyBusiness-to-Business (B2B)Healthcare Information TechnologyBusiness DevelopmentLife SciencesResearchEpidemiologyMedicineManagement ConsultingMedical EducationFrom Jonathan's professional profile.
Investments
Per the firm's website.
Colleagues at Industrifonden
Andreas Hiller
Investor at Industrifonden
Andreas Söneby
Investor at Industrifonden
Anna Haupt
Investor at Industrifonden
Anna Ljungdahl
Investor at Industrifonden
Åsa Hedin
Investor at Industrifonden
Åsa Sundberg
Investor at Industrifonden
Birgitta Stymne Göransson
Investor at Industrifonden
Caroline Murray
Investor at Industrifonden
Frequently asked questions
- Who is Jonathan Ilicki?
- Jonathan Ilicki is part of Industrifonden's life science team, with a background spanning clinical practice, research, entrepreneurship, and management consulting. He previously worked as a physician, co-founded a medtech startup, scaled operations for a digital healthcare provider, and led growth and internationalization for a VC/PE-backed healthtech scale-up. He holds an MD from Karolinska Institutet, an Executive MBA from the Stockholm School of Economics, and a master's degree in Evidence-Based Medicine from the University of Gothenburg.
- Where does Jonathan Ilicki work?
- Jonathan Ilicki is Investment Manager at Industrifonden.
- What does Jonathan Ilicki invest in?
- Jonathan Ilicki invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What companies has Jonathan Ilicki invested in?
- Investments tracked here include Airsonett, Asgard Therapeutics, BOOST Pharma, Elypta, Gesynta Pharma, Nuvoair, Toxotech, Tribune Therapeutics AB, Zymego.
- Where did Jonathan Ilicki go to school?
- Jonathan Ilicki studied at Stockholm School of Economics (Executive MBA); MIT Sloan School of Management (Artificial Intelligence in Health Care Executive Course); University of Cambridge (High Impact Leadership Executive Course. Grade: Excellent (97%)).
Same school
Also attended Stockholm School of Economics215
Jeppe RindomCo-founder & CEO of PleoVictor JacobssonCo-founder of Klarna; investorJosefin LandgårdCo-founder & CEO of MANTLE; co-founder of KryMattias LjungmanInvestor at Moonfire VenturesPär-Jörgen PärsonPartner at NorthzoneJessica SchultzPartner at Northzone
+ 209 more
Also attended MIT Sloan School of Management518
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 512 more
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 887 more
Also attended University of Gothenburg48
Martin Boldt-ChristmasInvestor at Green FlagPelle TornbergInvestor at FELIX CAPITALFredrik LehmannInvestor at IndustrifondenDr. Christopher OsterFounder and former CEO of CLARK at PICUS CAPITALAnna GisselssonInvestor at Almi InvestEmma BurmanInvestor at Almi Invest
+ 42 more
Shared employers
Also worked at Gesynta Pharma AB3
Also worked at Obama Foundation11
Fridtjof DetznerCo-Founder & General Partner at Planet A VenturesAmarit CharoenphanInvestor at NZVCChelsea ZhangInvestor at Equal VenturesLubomila JordanovaAdvisor at SatganaIbraheem AlinurVice President at 2Flo VenturesUsman IftikharCo-Founder & CEO at Catalysr
+ 5 more
Also worked at The Boston Consulting Group (BCG)907
David SzeAdvisory Partner at GreylockDave MunichielloInvestor at GV (Google Ventures)Massimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 Ventures
+ 901 more







































.png)

























/https%3A%2F%2Fbonniercapital.se%2Fwp-content%2Fuploads%2F2023%2F02%2FSofia-3.jpg)
/https%3A%2F%2Fbonniercapital.se%2Fwp-content%2Fuploads%2F2023%2F01%2Fnadja.jpeg)